Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? AZ resident? California.

Legislation 244

Legislation Patients Decriminalization Access 244

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. What about other medical cannabis products? ” Source BBC: [link]. PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MMJ Recs

APRIL 1, 2024

Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 1, 2022

Medical cannabis and psychedelics are being increasingly recognised by health professionals for their superior safety and efficacy compared to conventional pharmaceuticals. Due to its illegality and stigma, patients greatly suffered from an inability to access this medicine.

Pharmaceutical 52

Pharmaceutical Medicine Safety Epilepsy 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

MMJ Recs

NOVEMBER 20, 2023

These compounds may help reduce symptoms and improve the quality of life for patients. Cannabis Research and Patient Outcomes The scientific exploration of cannabinoids and their therapeutic effects has opened the door to numerous research initiatives. The outcomes of these studies have had a profound impact on patient care.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. ND resident?

Legislation 201

Legislation Decriminalization Hemp Patients 201

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

NORML

FEBRUARY 1, 2019

Click here to email your lawmakers in support of banking access. Legislation is pending, House Bill 6849, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit medical cannabis patients to grow up to six cannabis plants. CA resident? CT resident?

Legislation 167

Legislation Decriminalization Access Patients 167

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. The report further breaks down use by specific cultivars.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

FEBRUARY 29, 2020

Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. Send a message to your lawmakers in support of access to edibles. Send a message to your lawmakers in opposition to arbitrary THC limits. GA resident? HI resident?

Legislation 148

Legislation Decriminalization Patients Edibles 148

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. About Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

JULY 19, 2021

We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. That is perhaps the biggest lie that is being perpetuated on the Alabama public today.

Legalization 70

Legalization Pharmaceutical Therapy Chronic Pain 70

Veriheal

NOVEMBER 10, 2020

The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. In conjunction with the ANSM, the Ministry of Health and Solidarity will decide on the following: The characteristics, composition, pharmaceutical form, and technical specifications of the medical cannabis products. .

Chronic Pain 72

Chronic Pain Pharmaceutical Patients Epilepsy 72

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JANUARY 19, 2022

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. Waldhausklinik is a non-profit acute care hospital for internal medicine in the Free State of Bavaria and has entered into a research collaboration with AMP into the efficacy and safety of medical cannabis.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

The Cannigma

FEBRUARY 4, 2021

When it comes to cannabis and the struggle for legalization, improving access, and changing hearts and minds, advocates often find themselves up against decades-old myths, misconceptions, and stereotypes that have been delivered from authoritative sources for so long that for many people they supplant the truth. grandbrothers/123rf).

THC 145

THC Cannabinoids Blood Pressure Conditions 145

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JANUARY 10, 2020

Being a member of the Drug Science Medical Cannabis Working Group, Schlag’s current research focuses on the controversies surrounding medical cannabis and the application of MultiCriteria-Decision-Analysis to assess benefits and safety. Deepak Anand. Deepak Anand is recognised as a thought leader in the global cannabis space.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

NOVEMBER 22, 2019

. “As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

MAY 8, 2022

I have an extensive background in healthcare and have worked in the community, aged care and palliative care sectors as well the corporate (pharmaceutical and insurance) sectors. Through my personal experiences, many patient interactions and my own education. Road Safety laws to be amended to allow for a defence for medicinal users.

Education 98

Education Medicine Cannabinoids Programs 98

Cannabis Law Report

JANUARY 21, 2019

Britain tweaked legislation in November 2018 to allow specialist doctors in the UK to prescribe cannabis-based medicines to patients managing a wide range of symptoms – from chronic pain, chemotherapy-induced nausea and vomiting, to muscle spasticity for those with multiple sclerosis.

Chronic Pain 72

Chronic Pain Medicine Education Patients 72

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. As we prepare for a potential world-class launch of Vicineum, I strongly believe that these leaders will not only bring diverse and invaluable expertise to our team but will also drive the Company to continue executing our mission to save and improve the lives of patients with cancer.”.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

JANUARY 24, 2020

Hemp Industry Daily reports…… Another product has been approved for use under Ireland’s Medical Cannabis Access Programme (MCAP). Two products were approved for use last year – High CBD Oil Drops from Aurora and CannEpil, which is produced by ASX-listed MGC Pharmaceuticals. It contains 9.6

Oil 59

Oil Epilepsy Conditions Treatment 59

Cannabis Law Report

DECEMBER 22, 2019

Last month the NHS struck a deal with the manufacturer GW Pharmaceuticals to bring down the price of Epidiolex, which has been approved by the European medicines agency for use in children over the age of two who suffer from seizures associated with two rare and severe forms of epilepsy – Lennox-Gastaut syndrome (LGS) and Dravet syndrome. .

Epilepsy 59

Epilepsy Medicine Treatment Pharmaceutical 59

The Cannigma

JULY 1, 2022

These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. Moreover much of the research done has focused on synthetic pharmaceutical grade cannabinoids developed by pharmaceutical companies. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108